Kadimastem Ltd
KDST
Rank in Stocks
#40943
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Share Price
$12.16
Last synced: 2025-10-30
Market Cap
$50.98K
Change (1 day)
-0.10%
Change (1 year)
69.56%
Country
IL
Trade Kadimastem Ltd (KDST)
Category
Healthcare
Stock price history for Kadimastem Ltd (KDST)
Highest end of day price: $3.43 on 2025-12-01
Lowest end of day price: $8.68 on 2021-01-01
Lowest end of day price: $8.68 on 2021-01-01
Stock price history of Kadimastem Ltd from 2021 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 29.04% |
| 2025 | -62.21% |
| 2024 | -1.52% |
| 2023 | 0.00% |
| 2022 | -67.49% |
| 2021 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $528.42 | 23.96% |
US
|
|
| $251.97 | 816.57% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $889.73 | 6.59% |
NL
|
|
| $752.87 | 7.40% |
CH
|
